Veery Capital, LLC

Position in ABBV — AbbVie Inc.

CIK 1844375 Wilmington, DE

Position in ABBV

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$224,211

+$24,054 QoQ

Shares Held

891

+1.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

#3,877

of 4,153 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Veery Capital, LLC holds $1,998,644 across 6 Drug Manufacturers - General names. ABBV ranks #6 (11.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,691	$429,463
2	LLY	ELI LILLY & Co	308	$369,424
3	MRK	Merck & Co., Inc.	2,664	$342,324
4	AZN	Astrazeneca PLC	1,787	$338,850
5	GILD	Gilead Sciences, Inc.	2,330	$294,372
6	ABBV	AbbVie Inc. This page	891	$224,211

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$224,211	891	+1.7%	Shares	Sole	2026-07-09
2025-12-31	$200,157	876	-38.1%	Shares	Sole	2026-01-27
2024-12-31	$251,623	1,416	-4.0%	Shares	Sole	2025-01-15
2024-09-30	$291,283	1,475	-7.5%	Shares	Sole	2024-11-06
2024-06-30	$273,574	1,595	+0.6%	Shares	Sole	2024-07-18
2024-03-31	$288,628	1,585	+0.3%	Shares	Sole	2024-04-19
2023-12-31	$244,852	1,580	-2.5%	Shares	Sole	2024-01-10
2023-09-30	$241,477	1,620	+0.1%	Shares	Sole	2023-10-13
2023-06-30	$217,993	1,618	-1.7%	Shares	Sole	2023-07-13
2023-03-31	$262,323	1,646	-2.3%	Shares	Sole	2023-04-13
2022-12-31	$272,151	1,684	+3.9%	Shares	Sole	2023-01-17
2022-09-30	$217,554	1,621	+1.6%	Shares	Sole	2022-10-12
2022-06-30	$244,290	1,595	-8.4%	Shares	Sole	2022-07-18
2022-03-31	$282,395	1,742	+8.9%	Shares	Sole	2022-04-18
2021-12-31	$216,504	1,599	—	Shares	Sole	2022-01-13
No filing history on record for this holder in this stock.